Neurodegenerative conditions, also known as degenerative neurological disorders, refer to a diffuse set of disorders that cause a progressive decline in cognitive and motor functions. The most common of these include Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Huntington’s disease, and multiple sclerosis, but there are numerous other less common forms of neurodegenerative disease. Neurodegenerative conditions are typically caused by a gradual and accumulative damage to the brain cells. Over time, these cells can become too damaged to perform their normal functions and eventually die off. This can result in a loss of crucial motor and cognitive functioning, causing symptoms such as impaired speech, difficulty walking, impaired memory, and personality changes. Underlying biological mechanisms of neurodegenerative conditions are complex and largely unknown. They involve a combination of genetic, environmental, and lifestyle factors that can cause the disease to progress. In many cases, the cause of neurodegenerative diseases is still a mystery. Treatment for these conditions is based on managing and alleviating symptoms rather than curing the disease. The treatment typically involves a combination of medications, physical and occupational therapy, and lifestyle modification.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States